Revenue
2023
EXOZYMES INC. (EXOZ)
Price—Loading quote
Net income
2023
2024
2025
Free cash flow
2023
2024
2025
Total cash / debt
CashTotal debt
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Revenue | — | — | $70,069 |
| Research & development | $3.7M | $1.9M | $527,480 |
| Operating expenses | $9.7M | $5.9M | $1.9M |
| Operating income | −$9.7M | −$5.9M | −$1.8M |
| Net income | −$9.2M | −$5.9M | −$2.0M |
| Basic EPSper diluted share | -$1.09 | -$0.89 | -$0.33 |
| Diluted EPSper diluted share | -$1.09 | -$0.89 | -$0.33 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Apr 9, 2026Form 4 | Korman Tyler PazChief Scientific Officer | SellCOMMON STOCK | 750 | $10.53 | $7.9K | 729.1K |
| Apr 8, 2026Form 4 | Korman Tyler PazChief Scientific Officer | SellCOMMON STOCK | 750 | $10.04 | $7.5K | 729.9K |
| Jul 2, 2025Form 4 | Heltzen MichaelChief Executive Officer | BuyCommon Stock | 1.0K | $10.22 | $10.6K | 10.6K |
| Jan 17, 2025Form 4 | Heltzen MichaelChief Executive Officer | BuyCommon Stock | 1.8K | $10.78 | $19.0K | 3.9K |
| Jan 16, 2025Form 4 | Heltzen MichaelChief Executive Officer | BuyCommon Stock | 121 | $10.72 | $1.3K | 2.1K |